BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. (ticker: BRTX) is an NASDAQ-listed services-misc health & allied services, nec company. DredgeCap's structured extraction of BRTX's SEC filings surfaces 11 active risk signals, including 10 late-filing signals, and 1 auditor-change signal. BRTX reported $23K in revenue and -$2.15M for the period ending 2026-03-31, with operating cash flow of -$3.81M. Cash and equivalents stood at $3.11M (up 153.3% year-over-year). Total assets of $4.64M exceed total liabilities of $3.67M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.